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Abstract 
 
Objective. Nerves in the peripheral nervous system (PNS) contain axons with specific motor, 
somatosensory and autonomic functions. Optogenetics offers an efficient approach to selectively 
activate axons within the nerve.  However, the heterogeneous nature of nerves and their tortuous route 
through the body create a challenging environment to reliably implant a light delivery interface. 
Approach. Here, we propose an optical peripheral nerve interface – an optocuff -, so that optogenetic 
modulation of peripheral nerves become possible in freely behaving mice. Main results. Using this 
optocuff, we demonstrate orderly recruitment of motor units with epineural optical stimulation of 
genetically targeted sciatic nerve axons, both in anaesthetized and in awake, freely behaving animals. 
Behavioural experiments and histology show the optocuff does not damage the nerve thus is suitable 
for long-term experiments. Significance. These results suggest that the soft optocuff might be a 
straightforward and efficient tool to support more extensive study of the PNS using optogenetics.    
 
 
1. Introduction 
 
Optical neural stimulation is emerging as an exciting and more advantageous alternative to traditional 
electrical stimulation.  The conductive nature of biological tissue leads to electrical current spread, 
limiting spatial resolution and preventing cell-specific activation (Fenno et al., 2011, Warden et al., 
2014). Genetic modification of neurons to express opsins, i.e. light-sensitive proteins on neuronal 
Page 1 of 17 AUTHOR SUBMITTED MANUSCRIPT - JNE-102003.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
membranes, renders neurons sensitive to light of a specific wavelength with millisecond precision 
(Boyden et al., 2005). In the last decade, optogenetics has been used extensively to modulate neural 
activity in the central nervous system (Deisseroth, 2015).  In 2016, a human trial of optogenetics to 
treat retinitis pigmentosa, a degenerative disease in which the specialized light-sensitive photoreceptor 
cells in the eye die, was launched (clinicaltrials.gov # NCT02556736). 
The use of optogenetics in the peripheral nervous system (PNS) has to date been relatively modest, 
however, compared to optogenetic control in the brain (Montgomery et al., 2016, Jeschke and Moser, 
2015), because of several physiologic and technological challenges.  Peripheral nerves are complex, 
heterogeneous tissues embedded in muscle and connective tissue, which strongly scatter and absorb 
visible light.  Nerves vary significantly in length and diameter, with small visceral nerves 100 times 
smaller than larger nerves, such as the sciatic nerve.  Peripheral nerve stimulation is often conducted in 
awake, freely moving animals as anesthesia alters nerve excitability properties.  Under normal 
physiologic conditions, peripheral nerves are stretched as joints move and muscles elongate, making 
consistent light delivery complex.  Methods similar to those used in the brain can be used to express 
opsins in peripheral neurons; however several groups have reported on the difficulties in doing so with 
sufficient stability and efficacy and without interfering with the regular function of the peripheral 
neurons (Miyashita et al., 2013).  
Controlled and long-term light delivery to peripheral nerves requires advances in neurotechnology to 
both enable long-lasting and efficient opsin expression in specific subsets of axons in peripheral 
nerves and the production of implantable interfaces biointegrated with the flexible nerves and capable 
of sufficient light power delivery over extended periods of time without producing nerve damage.  
In a pioneer study, Llewellyn et al. demonstrated that optical stimulation of motor units in a nerve of a 
transgenic mouse expressing the light-activated cation channel ChR2 in Thy1+ neurons better 
approximated physiological recruitment of motor fibers than electrical stimulation (Llewellyn et al., 
2010). For the first time, this study presented an optoelectronic implant for optical modulation of the 
sciatic nerve.  However, the stiffness of the hybrid implant hosting 16 millimeter-side light emitting 
diodes (LEDs) limited its application to acute, anaesthetized conditions only.  
Transdermal optical stimulation is a non-invasive alternative approach to optogenetic stimulation of 
peripheral sensory neurons.  Excitation (Daou et al., 2013, Browne et al., 2017, Arcourt et al., 2017) 
and inhibition (Iyer et al., 2014, Daou et al., 2016) of mouse primary afferent neurons have been 
demonstrated using such a design but efficient control of axon activation strongly depends on the 
optical properties of the intermediate tissues e.g. skin and subcutaneous tissue (Maimon et al., 2017, 
Montgomery et al., 2016). Effectively, stimulation is limited to nerve terminals in the skin whose 
superficial epidermal layers are innervated by nociceptors. Direct optical stimulation of nerves using 
an implant is a promising approach for chronic PNS optogenetics. The question is how best to do this? 
The rapidly expanding use of optogenetics in the CNS has triggered development of a variety of 
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optoprobes in the form of waveguide, miniaturized optical fibers and optoelectronic μLED-based 
arrays (Iseri and Kuzum, 2017, Fan and Li, 2015, Wu et al., 2013, Pisanello et al., 2017, Canales et al., 
2015, Alt et al., 2017) yet very few answer the technical needs for chronic peripheral nerve 
optogenetics.  
Inspired by the report from Towne et al. on an optical fiber-based nerve cuff for optical stimulation in 
freely-behaving rats (Towne et al., 2013), we have constructed a soft and biointegrated optocuff as an 
optical neural implant for chronic peripheral optogenetic stimulation in freely-behaving mice. The 
optocuff delivers blue light to axons expressing channelrhodopsin (ChR2) in transgenic mice. We 
overcame chronic implantation challenges with a miniaturized cuff design with soft materials and 
motion-compliant optic fibers. We demonstrate optical muscle activation with epineural stimulation of 
Thy1 expressing motor axons and a stable nerve-implant interface after 20 days in vivo. This optocuff 
enables broad optogenetic neuromodulation of peripheral axons and is likely to contribute to the 
evaluation of using this strategy for new therapeutic interventions for the impaired PNS.    
 
2. Methods 
 
2. 1.  Mice 
All mice were purchased from Jackson Laboratories and Thy1-Cre mice were backcrossed to 
C57BL/6 for at least 5 generations. Targeted expression of ChR2-tdTomato was achieved by breeding 
heterozygous Rosa-CAG-LSL-hChR2(H134R)-tdTomato-WPRE (Ai27D) mice with Thy1-Cre mice. 
Resultant Thy1-Cre::ChR2 mice were heterozygous for both transgenes and were housed with control 
littermates. Mice were given ad libitum access to food and water and were housed in at 22 ± 1°C, 50% 
relative humidity, and a 12-hr light:12-hr dark cycle. Male and female mice were pooled by genotype 
to limit the number of animals used. All experiments were conducted according to institutional animal 
care and safety guidelines and with IACUC approval at Boston Children’s Hospital, and accordance 
with Swiss federal legislation and under the guidelines established at EPFL and approved by local 
Swiss Veterinary Offices. 
 
2. 2.  DRG neuron culture and electrophysiology 
Dorsal root ganglia neurons were isolated from adult (3-6 month old) mice and maintained at 37 °C in 
5% carbon dioxide. Electrophysiological recordings were made at 20-22 °C up to 24 h after DRG 
neuron dissociation, using the whole-cell configuration of the patch-clamp technique. Recording 
pipettes had tip resistances of 4–8 MΩ when filled with (in mM): 135 K-gluconate, 10 KCl, 1 MgCl2, 
5 EGTA, and 10 HEPES, pH 7.3. The extracellular solution contained (in mM): 145 NaCl, 5 KCl, 2 
CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose, pH 7.4. All solutions were maintained at 300–315 
mOsm/l. Membrane potential was recorded in current clamp mode with an Axopatch 200A amplifier 
and Digidata 1400A A/D interface using pClamp 10.2 software (Molecular Devices). The data were 
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low-pass filtered at 5 kHz (4-pole Bessel filter) and sampled at 10 kHz. Input resistance was typically 
>500 MΩ, and cells with resistances <200 MΩ were discarded. Care was taken to maintain membrane 
access resistance as low as possible (usually 3–7 MΩ and always less than 10 MΩ). Detailed methods 
can be found in (Browne et al., 2017). 
 
2. 3.  Nerve optical properties 
Sciatic nerves of 5 naïve adult mice were carefully explanted after CO2 asphyxiation, immersed in 
PBS then embedded in 2.5% agarose gel. Cross-sectional slices (100-1000 µm thick) were obtained 
with a vibratome apparatus (VTS1200, Leica) and mounted on microscopic glass slides (Superfrost, 
Thermo Scientific). A drop of saline was added to prevent slices from drying. Tissue transmittance 
was immediately measured with an optical system composed of a photodiode (S170C, Thorlabs), a 
power meter console (PM100D, Thorlabs) and a 473 nm DPSS laser (100 mW, LaserGlow) coupled to 
a multimode SMA optic fiber (105 µm core diameter, 1 m length, Thorlabs). The sensor was shaded 
with a mask matching nerve cross-section dimensions and a constant intensity (15 mW.mm-2) 
illuminated the slices. The light radial distribution in sciatic nerve tissue was finally modeled using the 
modified 1D Beer-Lambert law:  𝐼 𝑧 = 𝐼$ ∗ 𝑒 '()**	∗	,  
 
where I0 is the optic fiber output irradiance, µeff the effective attenuation coefficient and z the slice 
thickness (Al-Juboori et al., 2013).  
 
2. 4.  Optocuff construction 
The cuff was built upon a polystyrene rod template (0.88 mm diameter, Evergreen). A soft 150 µm 
thick platinum-catalyzed silicone (Ecoflex 00-50, Smooth-On) was vertically spin-coated and cured (2 
h at 80 °C). A gold film was sputtered (80 nm, DP650, Alliance Concept) on the silicone to act as a 
light reflective coating. Finally, a micrometric film of Polydimethylsiloxane (PDMS) (Sylgard 184, 
Dow Corning) was used for encapsulation by spray deposition of a PDMS–Heptane mixture. A 12 cm 
optic fiber (FG105UCA, 105 µm inner core diameter Thorlabs) was processed similarly to previous 
papers (Sparta et al., 2011). Briefly, the acrylate coating tip-end of the fiber was dissolved in acetone 
and terminated with a 1.25 mm ceramic ferrule (CFLC128, Thorlabs). The fiber was then polished 
using a dedicated kit (Thorlabs) and its light transmission controlled with a power sensor. The distal 
end of the fiber was perpendicularly coupled to the cuff template and polymer sealed (Kwik-Sil, 
World Precision Instruments). Finally, the rod was carefully removed, the cuff trimmed (2 mm length, 
0.8 mm inner diameter) and a sharp incision was applied transversally to the cuff. The compressive 
stress built during elastomer curing caused the cuff to spontaneously fold spirally.    
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2. 5.  Optocuff implantation 
All animal procedures were approved by the institutional animal care and safety guidelines and with 
IACUC approval at Boston Children’s Hospital. Healthy adult (3-6 month old) male and female Thy1-
Cre::ChR2 mice of average mass 27.5 g were implanted with the optical cuff. Mice were anesthetized 
under isoflurane (1–3%) and the body temperature was maintained with a heated surgical table (37 
°C). The left hindlimb and head of the mouse were shaved and the skin disinfected using successive 
applications of betadine and isopropyl alcohol. Under sterile conditions, a skin incision exposed the 
skull, where 2 precision screws were drilled. The sciatic nerve was exposed at the mid-thigh level after 
a parallel 1 cm long skin incision and blunt muscles separation. The optical cuff and optic fiber were 
threaded subcutaneously, the ferrule end laying down the mouse skull and the cuff proximal to the 
sciatic nerve. A loop was formed on the optic fiber so the cuff has a 90 ° incidence angle on the sciatic 
nerve and to relieve the strain along the fiber after implantation. The cuff was then applied to wrap the 
sciatic nerve and a loose suture secured the optic fiber to surrounding muscles. The separated muscles 
were sewed back together with absorbable sutures. The ferrule was anchored to the skull with a small 
amount of dental cement, and the incisions at the head and hindlimb closed with sutures (6-0, 
Ethicon). Full surgical procedure took 45 minutes. Control mice used in behavioural experiments 
underwent similar surgical procedure with the skull and sciatic nerve being exposed. Only a ferrule 
fixed on a 1 cm long optic fiber was mounted on the skull so blinded experimenters could not 
distinguished experimental groups. Mice were allowed to recover in single housed cage and 
subcutaneously injected with post-operative meloxicam analgesic for 3 days. 
 
2. 6.  EMG electrode implantation and data acquisition 
All surgical procedures were performed in accordance with Swiss federal legislation and under the 
guidelines established at EPFL and approved by local Swiss Veterinary Offices. The animals were 
administered general anesthesia (mixture of 80 mg/ml ketamine, 10 mg/ml xylazine, diluted in saline), 
using intraperitoneal injection s (8.5 ml/kg). Bipolar intramuscular electrodes (AS632, Cooner Wire) 
were inserted unilaterally in the tibialis anterior (TA, ankle flexor) muscles to record 
electromyographic activity. Recording electrodes were created prior to implantation by removing a 
small part (~200 µm notch) of Teflon insulation. All the wires were connected to a percutaneous 
amphenol connector (Omnetics Connector Corporation). EMG recordings were synchronized with the 
laser stimulation onset using a custom-developed Tucker-Davis Technology (TDT) code. Signals were 
amplified (x1000) and pre-filtered (Bandpass: 100 Hz -1 kHz) with an AM systems amplifier. 
 
2. 7.  Optogenetic control and high-speed behavioural imaging 
The optical cuff was coupled to the laser with a multimode FC/PC optic fiber cable (105 µm core 
diameter, 2 m length, Thorlabs) using a ceramic mating sleeve (ADAL1, Thorlabs) on the ferrule. It 
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was critical avoiding any physical stress on the mouse during the operation. Mice were housed in a 
small chamber (7.5 x 7.5 x 15 cm3) chambers and acclimatized for at least 30 minutes. A counter-
balance lever arm (Harvard Apparatus) relieved the mouse from the laser optic fiber cable weight. A 
computer-controlled pulse generator (OPTG-4, Doric) was used to supply TTL signals to the laser 
driver. Simultaneous epineural optogenetic stimulation (average 40 mW laser output) and high-speed 
recordings were performed. Behaviour was sampled at 1000 frames per second using an acA2040-
180kmNIR cameralink CMOS camera (Basler) with a 8 mm lens and set at 500 pixels x 350 pixels. 
Acquisition was carried out in LabVIEW on a computer with excess buffer capacity to ensure all 
frames were successfully retained. Littermate control mice without Cre recombinase and implanted 
with the optical cuff did not react to blue light pulse (20 ms, 60 mW). Cuff implanted Thy1-Cre::ChR2 
mice did not respond to an equivalent off-spectra pulse of light (594 nm, LaserGlow).  
 
2. 8.  Behavioral experiments  
All experiments were conducted in a quiet room at 22 ± 1°C with 50% relative humidity. Animals 
were acclimatized to the behavioral testing apparatus during three habituation sessions in advance of 
starting the experiment. The behavioral tester was blinded until the experiment was complete.  
 
2. 8. 1. Mechanical sensitivity 
Mice were habituated, single housed in a small transparent chamber (7.5 x 7.5 x 15 cm3) elevated on a 
wire grid. Mechanical sensitivity was measured by applying an increasing perpendicular force to the 
lateral plantar surface of the left hindpaw using graded series of six von Frey filaments (with bending 
force of 0.04, 0.07, 0.16, 0.4, 0.6, 1 g) and counting the number of withdrawal responses across ten 
applications. The pain mechanical threshold was defined as the minimal force triggering at least 5 
withdrawals.  
 
2. 8. 2. Thermal sensitivity 
Each mouse was habituated on a warmed (29 °C) glass platform of a Hargreave’s apparatus (IITC Life 
Science). Thermal sensitivity was determined by applying a radiant heat source to the plantar hindpaw 
while measuring the duration before hindpaw withdrawal. The latency for the onset of nocifensive 
behavior was timed. This latency was determined 3 times per animal, per session, with a 5 minutes 
interval to prevent thermal sensitization.  
 
2. 8. 3. Dynamic weight bearing 
Mice inflammatory pain was assessed using a DWB test (Bioseb). Each mouse was placed 5 minutes 
in a Plexiglas chamber (11 x 19.7 x 11 cm3) with a pressure transducers array on the floor. A camera 
recorded each movement while the mouse was exploring the chamber. Using a software matching 
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pressure data and the video recordings, we discriminated and measured the weight (in grams) applied 
by the limbs. Finally, we extracted the duration of the cuff implanted hindpaw on the floor over the 
contralateral one.  
 
2. 8. 4. Motor sciatic nerve assessment 
Motor recovery in mice was assessed using a DigiGait apparatus (Mouse Specifics). Mice were 
recorded walking on the treadmill videography system at 20cm/s. Measures of toe spread (TS) and the 
print length (PL, distance of the 3rd toe tip to the most posterior paw part) were used to calculate the 
sciatic nerve functional index (SFI) using the following formula (Baptista et al., 2007):  
𝑆𝐹𝐼 = 	118.9	 ∗ 	 TSleft − TSrightTSright – 	51.2 ∗ 	 (PLleft − 	PLright)PLright 	– 	7.5 
 
2. 9.  Tissue preparation and fluorescence imaging  
Mice were anesthetized with pentobarbital (100 mg.kg-1 intraperioneal) and fixed by transcardial 
perfusion with 4% paraformaldehyde dissolved in phosphate buffered saline (PBS). DRG (L3-L5) and 
sciatic nerves were dissected, postfixed, washed, cryoprotected with sucrose in PBS (30% w/v) for 2-3 
days, and frozen (O.C.T., Tissue-Tek). Cryosections of DRG (10 μm thick) and sciatic nerves (10 µm 
longitudinal sections, 10 µm cross-sections) were blocked with 1% bovine albumin serum (BSA) and 
0.1% triton X-100 in PBS for one hour. Sections were incubated with NF200 (1:2000), CGRP (1:500) 
primary antibody in fresh blocking solution overnight at 4°C and washed three times (10 minutes 
each) in saline. They were then incubated with secondary IgG antibody (1:500, Life Technologies) for 
one hour at room temperature, washed three times (10 minutes each) in PBS, and mounted in 
Vectashield (H-1200). Fluorescein-conjugated GSL I was used at 1:1000. Finally, sciatic nerve cross-
sections were incubated with DAPI (1:1000, 15 minutes, Sigma) and washed in PBS. DRG and sciatic 
nerve sections were imaged using a Nikon Eclipse 80i microscope using a Nikon 10X objective and 
Nikon DS-Qi1MC camera. In DRG and sciatic nerves, fluorescence corresponding to tdTomato was 
absent in tissues from littermate mice that did not express ChR2-tdTomato or that did not express the 
Cre recombinase 
 
3. Results  
 
3. 1.  Functional expression of ChR2 in the PNS  
The light-activated ion channel ChR2 was expressed in a broad class of sensory and motor neurons 
using a Cre-recombinase transgenic approach (Campsall et al., 2002); Cre-dependent ChR2-tdTomato 
mice were crossed with Thy1-Cre driver mice. The resultant Thy1-Cre::ChR2 mice were heterozygous 
for both transgenes and ChR2 was found in dorsal root ganglion (DRG) neurons and in sciatic nerve 
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axons (fig. 1 A, B). Of the ChR2+ DRG neurons, 41% were myelinated (NF200), 4% were CGRP+ 
and 5% IB4+. Electrophysiological studies using whole-cell current clamp recordings from ChR2-
tdTomato+ DRG neurons showed action potentials were elicited by light (fig. 1 C). The large range of 
membrane capacitances ([11 – 51] pF; mean 28 ± 4 pF) and thresholds ([ -56 – -35] mV; mean -44 ± 2 
mV) indicate a broad neuron population was targeted (Browne et al., 2017), as expected for the Thy1 
promoter. Functional expression of ChR2 at the mid-axon enables an epineural light-delivery strategy.  
 
 
 
 
 
 
 
Figure 1: Expression of ChR2 in the PNS of Thy1-Cre::ChR2+ mice. A) Expression of ChR2-tdTomato in DRG 
soma was found in a broad class of neurons, myelinated (NF200+, top left), CGRP+ (top right) and IB4+ 
(bottom left). White arrows indicate overlapping fluorescence emitting neurons. Scale bar 20 µm. ChR2 was 
expressed in a wide range of cell sizes as estimated using NeuN+ as a marker for all neurons (bottom right). B) 
Expression of ChR2-tdTomato in sciatic nerve fibers. Scale bar 100µm. Fluorescence was not observed in any of 
the littermate controls. C) Whole-cell current clamp recordings of action potentials elicited by light in cultured 
ChR2-tdTomato+ DRG neurons (17 neurons, 3 mice). These cells displayed a wide range of membrane 
capacitances and thresholds. Neurons from littermate controls did not show any effect of light (6 neurons). Light 
(473 nm for 3 ms) applied at 6 mW.mm-2. 
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3. 2. A mouse soft, implantable optical cuff 
We designed the optocuff as a soft, tubular construct that can be delicately wrapped around a mouse 
peripheral nerve, e.g. the sciatic nerve (fig. 2 A).  Light is delivered to the cuff and the nerve via a 
flexible optic fiber (105 µm core) subcutaneously threaded from a miniaturized headstage and 
anchored to the cuff. Multilayers of soft silicones (25kPa Young’s modulus) coated with a reflective 
thin gold film and a final PDMS film form the 2 mm long, 1 mm diameter cuff (fig. 2 B).  The 
reflective metallic coating limits light spill to the surrounding tissues.  The soft implant does not 
compress nor hinder the natural movement of the nerve as its elasticity surpasses that of the nerve (fig. 
2 C).   
 
 
 
 
Figure 2: Experimental system for optogenetic activation of the mouse PNS. A) Optical stimulation carried out 
epineurally in Thy1-Cre::ChR2 mice implanted with an optocuff. B) Optical cuff illustration. A thin flexible 
optic fiber terminates on a silicone rubber-based cuff to deliver an optical stimulation on the mouse sciatic nerve. 
A gold thin film enables light to reflect internally. C) Tensile strain-stress curves recorded from a fresh sciatic 
nerve immersed in physiological conditions and from the elastomeric cuff (n = 1 per group). D) Relative optical 
power transmission at 473 nm through fresh dissected sciatic nerve tissue (n = 4 per thickness).     
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We measured blue light transmission in vitro through slices of freshly dissected sciatic nerves.  Light 
is rapidly absorbed with an effective attenuation coefficient µeff  of 3.503 mm-1 at 473 nm tissues (fig. 2 
D).  We measured an average of 16% optical power losses from the optic fiber to the optocuff such 
that sufficient light power can be delivered at the optocuff to excite opsin-carrying axons. Heating 
within the optocuff is limited to photon absorption, a significant advantage compared to LED-based 
optoelectronic interfaces at analogous optical power (Yizhar et al., 2011).  
 
3. 3. Orderly muscle recruitment to optical stimulation 
To measure electromyographic (EMG) responses of anaesthetized Thy1::ChR2 mice to peripheral 
optical stimulation of motor axons the sciatic nerve of the mouse was exposed and implanted with the 
optocuff under general anesthesia (fig. 3 A). Then, thin EMG electrodes were inserted into the 
ipsilateral tibialis anterior (TA), an ankle flexor muscle innervated by the peroneal branch of the 
sciatic nerve. EMG recordings were synchronized with optical stimulation generated by an external 
473 nm laser. Short pulses of light consistently triggered unilateral TA contractions, resulting in light-
activated twitches. We characterized the muscle recruitment with the peak-to-peak value of EMG 
signal in the early phase of the response. We found the muscle fibers were recruited in an orderly 
fashion with the power of epineural irradiance of the optical stimulation (fig. 3 B, C). These results 
suggest more motor units were recruited with higher irradiance stimulation, consequently inducing 
larger muscle responses. Latency for the EMG onset (mean 6.1 ± 0.3 ms, 60 trials, 10 ms pulse width) 
was stable relative to the optical stimulation intensity and peak-to-peak amplitude (mean 6.1 ± 0.25 
mV), implying direct activation of large and fast motor axons. The TA EMG amplitude directly 
correlated with optical pulse width (fig. 3 D), indicating an increased activation of motor neurons with 
longer pulses. These results demonstrate peripheral optogenetic modulation in anesthetized mice with 
the optocuff.   
Next, we tested if the soft optocuff affects the sciatic nerve over time.  We implanted a group of Thy1-
Cre::ChR2 mice for 20 days with an optocuff wrapped around the left sciatic nerve; one end of the 
optic fiber was permanently anchored to its head-mounted ferrule. Histological cross-section of the 
nerve at the cuff site did not show any sign of demyelination or signs of inflammation after the 
prolonged implantation (fig. 4 A, B). Coherent with this, sensory and motor behavioral assessments 
did not reveal any change at various times after implantation. Thermal and mechanical pain-related 
assays as well as weight bearing and gait were conducted prior and after surgery and did not reveal 
any significant change (p > 0.05, ANOVA with Dunnett’s method) 
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Figure 3: Optical stimulation of the sciatic nerve in anaesthetized mice. A) Optocuff 
implantation on the sciatic nerve. Scale bar 2 mm. B-D, Optogenetic stimulation of 
peripheral axons in anaesthetized Thy1-Cre::ChR2 mice. Light-activated Tibialis Anterior 
EMG at various stimulation irradiances. The threshold for muscle contraction was 25 
mW.mm-2 (B). The blue bar indicates the stimulation duration (10ms). EMG amplitude is 
directly correlated with stimulation irradiance (C) and pulse width (D). (n = 3 Thy1-
Cre::ChR2 mice, 5 trials per condition; irradiance set at 60 mW.mm-2 ). 
 
 
 
3. 4. Epineural stimulation of motor neuron axons in awake mice 
Next, we tested whether the optocuff could reliably deliver epineural optical stimulation in awake, 
freely-behaving mice. We applied epineurally short (2-100 ms) light pulses at 473 nm with the 
optocuff while continuously monitoring the behavior of Thy1-Cre::ChR2 mice at 1kHz with a camera 
(Basler Ace acA2040-180km). Optogenetic stimulation of the Thy1 axons resulted in short latency 
hindlimb muscle contraction (fig. 5 A, B, Supp. V1). We observed global limb extension and paw 
opening with short (> 5 ms) blue illumination. Probability of behavioural response to optical 
stimulation was higher with longer pulses (fig. 5 C) and reached 100% for pulses longer than 20 ms. 
We found the delay for the change in behavior elicited by epineural stimulation was stable through 
different effective pulse duration (mean 17.9 ± 0.58 ms, fig. 5 D). Using conduction velocity analysis, 
we concluded these changes in behavior were elicited by direct activation of motor neurons (Steffens 
et al., 2012).  
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Figure 4: Histology and behavioural experiments reveals the optocuff is suitable for long-term 
implantation. A-B, Sciatic nerve cross-sectional images 20 days following cuff implantation 
(A) or sham surgery (B). C-D, Thermal (C) and Mechanical (D) sensitivity assessed with 
Hargreaves and von Frey respectively, in cuff implanted (n = 6) and control groups (n=3). 
Surgery was performed on day 0. E) Dynamic weight bearing analysis of the duration of time 
spent on the ipsilateral versus the contralateral hindpaw, before surgery (white) and 5 days 
post-surgery (optocuff implantation) (grey). F) Box plot representation of the functional sciatic 
index calculated gait analysis on treadmill (20 cm/s).   
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Figure 5: Optogenetic control of peripheral neurons in awake behaving mice. A) Behaviour sampled at 1 kHz 
elicited by a single pulse of light (50 ms, 40 mW.mm-2) applied to the sciatic nerve using the optocuff. Onset of 
the optical stimulation can be seen transdermally. Epineural optical stimulation of Thy1 axons in the sciatic 
nerve results in hindlimb muscle contraction and paw opening. B) Motion detection reveals the kinetics of this 
behaviour. The latency to the response was 17 ms (Supplementary video V1). This analysis was conducted by 
comparing the difference in pixel intensity between frames. C) Probability of behavioural response to an 
epineural optogenetic stimulus depends on the pulse width (n = 3 mice, 5 trials per condition). D) Response 
latency upon epineural activation of Thy1 neurons demonstrates more stability with longer pulses. The mean 
latency did not depend on pulse duration (n = 3 Thy1-Cre::ChR2+ mice, 5 trials per condition). Littermate 
control cuff implanted mice did not show any response to light stimuli.  
 
 
Furthermore, absence of response to optical stimulation carried with the optocuff in control littermate 
mice implies that light-responses were not caused by heat or visual artifact.  
 
 
4. Discussion  
 
We have developed an implantable optical interface that enables optogenetic modulation of the PNS in 
freely-behaving small animals such as mice. The soft optocuff can be wrapped around the sciatic nerve 
inducing minimal foreign body reaction. Using transgenic Thy1-Cre::ChR2 mice, direct and robust 
muscle activation was obtained by optical stimulation of axons in the sciatic nerve, both in 
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anaesthetized and awake animals. The muscular response can be finely tuned with the optical 
stimulation parameters i.e. pulse width and irradiance.  
 
Stable light delivery to neurons/axons in vivo has been challenging, particularly for applications in the 
spinal cord or peripheral nerves (Montgomery et al., 2016). The relative motion of these soft 
biological tissues prevent long-term and reliable interface with the stiff implants. Although studies 
have bypassed this problem by stimulating nerve-endings via transdermal illumination (Daou et al., 
2013, Iyer et al., 2014, Arcourt et al., 2017, Browne et al., 2017) or using implanted wireless LEDs 
(Montgomery et al., 2015, Park et al., 2015), interfacing the whole nerve directly offers a broad range 
of opportunities. We find that reducing the mechanical mismatch between the nerve and implant and 
optimizing the surgical procedure were key for successful long-term optical coupling with the mouse 
PNS. The system relies on compliant, subcutaneously tethered fibers that enable a higher intensity and 
thermally safer light stimulation compared to optoelectronic systems. Additionally, the commercially 
available external light-sources allow for a large range of solutions for future optogenetic experiments.    
Opsin expression in the mouse PNS was achieved using the transgenesis route. Although recent 
studies have exploited optogenetics in rats or primates (L et al., 2017, Pawela et al., 2016, Klein et al., 
2016), mice are still the predominant species used in the neurobiology field. This animal model 
presents obvious advantages for genetic manipulations, resulting in a large number of Cre-lines and 
Cre-dependent viral vectors available. We show that ChR2 opsin expression in PNS neurons was 
robust enough for optical modulation in vitro and in vivo. The optocuff system can be used for a wide 
variety of optogenetic experimental approaches, including activation as here and neural inhibition with 
opsins such as halorhodopsin (NpHr) or archaerhodopsin (Arch). Multi-spectra modulation using 
multimodal optic fibers will further broaden opportunities for the soft optocuff system (Chuong et al., 
2014, Berndt et al., 2014). 
Finally, long-term selective modulation of the PNS by light delivery offers new experimental 
opportunities. Optical stimulation of peripheral axons has great implications for muscle control and 
nerve regeneration (Bryson et al., 2014, Liske et al., 2013), for the study of sensory biology (Browne 
et al., 2017) and for autonomic output (Kim et al., 2015). Similarly, optogenetic inhibition in vivo will 
enable to tease out the functional role of specific neurons involve in complex disease mechanisms, 
such as tactile allodynia following nerve injury (Daou et al., 2016).  
In summary, soft optocuffs are a simple and efficient tool to probe the PNS with optogenetics.  Its 
manufacturing does not require extensive microfabrication processes. Further miniaturization and 
addition of a wireless head-mounted light source would allow for an even broader use of the implant, 
especially to study smaller nerves, such as autonomic and visceral nerves (Birmingham et al., 2014).  
Finally, the optocuff system supports optogenetics as a versatile tool to unravel the PNS function, an 
essential step with therapeutic outcomes in many diseases, such as chronic pain.   
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Supplementary Materials 
 
Video V1: Single-shot optogenetic stimulation of sciatic nerve axons with the behaving mouse 
sampled at 1 kHz. 
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